Christine Chung L.'s most recent trade in FibroGen Inc was a trade of 7,008 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on March 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroGen Inc | Christine Chung L. | SVP, CHINA OPERATIONS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 06 Mar 2025 | 7,008 | 294,544 (0%) | 0% | 0.4 | 2,733 | Common Stock |
| FibroGen Inc | Christine Chung L. | SVP, CHINA OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 781 | 295,325 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Christine Chung L. | SVP, CHINA OPERATIONS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 06 Mar 2025 | 422 | 294,903 (0%) | 0% | 0.4 | 165 | Common Stock |